We have three clear missions. The first one is to provide innovative therapies to patients. The second one is to generate return on investment for our investors who supported and trusted in our science from the very beginning. Thirdly, we want to demonstrate that in Italy, you can still build a science-based biotech company that will not be sold to multinational players